The side effects of newly discovered COVID strain XEC might not be more severe, but appears to be more contagious, ...

Dr. Albert Ko, an infectious disease physician and Yale School of Public Health professor, told “TODAY” the new variant is a recombinant of two other ... told NewScientist the newest round of vaccines ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...

UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...

Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

The risk for incident gout following RZV exposure was not increased among adults aged 50 years or older, according to study findings.

GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...

Among the 461,323 individuals who received at least 1 RZV dose, 1264 experienced new-onset gout within 60 days postvaccination; 302 patients were determined to have incident cases of gout, with no ...